Mostrar el registro sencillo del ítem

Artículo

dc.contributor.advisor
dc.creatorTorres, E.es
dc.creatorLópez Cerero, Lorenaes
dc.creatorNavarro, M. D.es
dc.creatorRodríguez-Baño, Jesúses
dc.creatorPascual Hernández, Álvaroes
dc.date.accessioned2024-02-01T13:45:10Z
dc.date.available2024-02-01T13:45:10Z
dc.date.issued2018
dc.identifier.citationTorres, E., López Cerero, L., Navarro, M.D., Rodríguez-Baño, J. y Pascual Hernández, Á. (2018). Prevalence and transmission dynamics of Escherichia coli ST131 among contacts of infected community and hospitalized patients. Clinical Microbiology and Infection (CMI), 24 (6), 618-623. https://doi.org/10.1016/j.cmi.2017.09.007.
dc.identifier.issn1198-743Xes
dc.identifier.issn1469-0691es
dc.identifier.urihttps://hdl.handle.net/11441/154428
dc.description.abstractObjectives: The Escherichia coli O25b-associated ST131 clonal group was recently found to be prevalent in our area as a cause of community-acquired urinary tract infections. We evaluated the transmission dynamics and longitudinal persistence of E. coli O25b-ST131 between patients with nosocomial and community-acquired infections and their contacts. Methods: Prevalence and transmission of O25b/pabB3/B23 isolates were compared in 38 community clusters, 30 nosocomial clusters and 50 healthy volunteers. Duration of colonization was studied at 1 to 4 months and 6 to 12 months after the first sample. Isolates exhibiting a three-band or less difference by pulsed-field gel electrophoresis were assigned to the same pulsotype. Results: Colonization was found to be more frequent in index cases (31/68, 45.6%) than in contacts (25/118, 21.2%; p 0.0009) or volunteers (1/50, 2%; p 0.0009). Seven (11%) of 64 isolates were extended-spectrum β-lactamase producers. Transmission occurred in 61% (8/13) community clusters and in 12% (1/8) nosocomial clusters. Thirteen (56.5%) of the 23 initial carriers assessed at 1 to 4 months remained colonized. Only 2 (13.3%) of 15 positive patients followed for 6 to 12 months showed prolonged carriage, and none was infected with extended-spectrum β-lactamase producers. Six previously positive individuals acquired a different ST131 pulsotype (5/23 at sample 2 and 1/15 at sample 3), and three previously negative individuals became positive (2/46 at 1-4 months and 1/33 at 6-12 months). Conclusions: Person-to-person transmission or acquisition from a common source of E. coli O25b-associated ST131 is more frequent in the household setting than in the nosocomial setting. The carrier state does not usually last beyond 4 months, with new acquisitions in certain individuals.es
dc.formatapplication/pdfes
dc.format.extent6 p.es
dc.language.isoenges
dc.publisherElsevieres
dc.relation.ispartofClinical Microbiology and Infection (CMI), 24 (6), 618-623.
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectEscherichia colies
dc.subjectHorizontal transmissiones
dc.subjectIntestinal carriagees
dc.subjectIntestinal persistencees
dc.subjectST131es
dc.titlePrevalence and transmission dynamics of Escherichia coli ST131 among contacts of infected community and hospitalized patientses
dc.typeinfo:eu-repo/semantics/articlees
dc.type.versioninfo:eu-repo/semantics/acceptedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Microbiologíaes
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Medicinaes
dc.contributor.affiliationUniversidad de Sevilla. Instituto de Biomedicina de Sevilla (IBIS)
dc.relation.projectID115523es
dc.relation.projectID115620es
dc.relation.projectID115737es
dc.relation.projectID070190es
dc.relation.projectID10/02021es
dc.relation.projectID10/01955es
dc.relation.projectID10/00795es
dc.relation.projectID0048/2008es
dc.relation.projectIDCTX-5259es
dc.relation.projectIDCTS210es
dc.relation.projectIDREIPI RD12/0015/0010es
dc.relation.projectIDREIPI RD16/0016/0001es
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/pii/S1198743X17305050?via%3Dihubes
dc.identifier.doi10.1016/j.cmi.2017.09.007es
dc.journaltitleClinical Microbiology and Infection (CMI)es
dc.publication.volumen24es
dc.publication.issue6es
dc.publication.initialPage618es
dc.publication.endPage623es
dc.contributor.funderEFPIAes
dc.contributor.funderEuropean Development Regional Fundes
dc.contributor.funderEuropean Uniones
dc.contributor.funderFondo de Investigacion Sanitariaes
dc.contributor.funderIndustria y Competitividades
dc.contributor.funderInnovative Medicines Initiativees
dc.contributor.funderInstituto de Salud Carlos IIIes
dc.contributor.funderJunta de Andaluciaes
dc.contributor.funderMinisterio de Economiaes
dc.contributor.funderOperative Programme INtelligent Growthes
dc.contributor.funderPlan Nacional de I+D+ies
dc.contributor.funderSpanish Network for Research in Infectious Diseaseses
dc.contributor.funderSubdireccion General de Redes y Centros de Investigacion Cooperativaes

FicherosTamañoFormatoVerDescripción
Prevalence and transmission ...786.7KbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Attribution-NonCommercial-NoDerivatives 4.0 Internacional